The DOI matches its Crossref record.
Abstinence symptoms following smoked marijuana in humans
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Crean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31820c23fa · Cited by 732
“Similarly, Haney et al. (1999) found that after acute intoxication, daily cannabis users significantly improved on a task of divided attention.”
BackgroundNeuropsychological Performance in Long-term Cannabis Users
Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.10.909 · Cited by 655
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587
Early-onset cannabis use and cognitive deficits: what is the nature of the association?
Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., & Yurgelun-Todd, D. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00334-4 · Cited by 543
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse
Allen, J. H., de Moore, G. M., Heddle, R., & Twartz, J. C. (2004) · Gut · doi:10.1136/gut.2003.036350 · Cited by 529
Review of the Validity and Significance of Cannabis Withdrawal Syndrome
Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1967 · Cited by 522
Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 481
Psychiatric effects of cannabis
Johns, A. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 469
The time course and significance of cannabis withdrawal.
Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.3.393 · Cited by 445
Marijuana and medicine: assessing the science base
(1999) · Choice Reviews Online · doi:10.5860/choice.37-2206 · Cited by 410
Drugs of abuse and the elicitation of human aggressive behavior
Hoaken, P. N. S., & Stewart, S. H. (2003) · Addictive Behaviors · doi:10.1016/j.addbeh.2003.08.033 · Cited by 405
High-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control
Ramaekers, J. G., Kauert, G., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Moeller, M. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301068 · Cited by 397
Neural substrates of faulty decision-making in abstinent marijuana users
BOLLA, K., ELDRETH, D., MATOCHIK, J., & CADET, J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.012 · Cited by 387
Angarita, G. A., Emadi, N., Hodges, S., & Morgan, P. T. (2016) · Addiction Science & Clinical Practice · doi:10.1186/s13722-016-0056-7 · Cited by 358
Drug abuse and aggression between intimate partners: A meta-analytic review
Moore, T. M., Stuart, G. L., Meehan, J. C., Rhatigan, D. L., Hellmuth, J. C., & Keen, S. M. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.05.003 · Cited by 355
The cannabis withdrawal syndrome
Budney, A. J., & Hughes, J. R. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218592.00689.e5 · Cited by 349
Chemical Probes of Endocannabinoid Metabolism
Blankman, J. L., & Cravatt, B. F. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006387 · Cited by 327
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.10.009 · Cited by 314
Brief treatments for cannabis dependence: Findings from a randomized multisite trial
Babor, T. F., & The Marijuana Treatment Project Research Group (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.3.455 · Cited by 313
Tanda, G., & Goldberg, S. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1485-z · Cited by 277
Effects of Acute Smoked Marijuana on Complex Cognitive Performance
Hart, C. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00273-1 · Cited by 271
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
Haney, M., Hart, C. L., Vosburg, S. K., Nasser, J., Bennett, A., Zubaran, C., & Foltin, R. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300310 · Cited by 264
Self-citationAdverse effects of cannabis on health: an update of the literature since 1996
Kalant, H. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.027 · Cited by 264
D'Souza, D. C., Ranganathan, M., Braley, G., Gueorguieva, R., Zimolo, Z., Cooper, T., Perry, E., & Krystal, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301643 · Cited by 262
Long-term heavy marijuana users make costly decisions on a gambling task
Whitlow, C. T., Liguori, A., Brooke Livengood, L., Hart, S. L., Mussat-Whitlow, B. J., Lamborn, C. M., Laurienti, P. J., & Porrino, L. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.04.009 · Cited by 253
The cannabis withdrawal syndrome: current insights
Bonnet, U., & Preuss, U. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s109576 · Cited by 221
Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms
Budney, A. J., Vandrey, R. G., Hughes, J. R., Moore, B. A., & Bahrenburg, B. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.014 · Cited by 180
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed205 · Cited by 184
Self-citationThe Marijuana Treatment Project: rationale, design and participant characteristics
Stephens, R. S., Babor, T. F., Kadden, R., Miller, M., & The Marijuana Treatment Project Research Group (2002) · Addiction · doi:10.1046/j.1360-0443.97.s01.6.x · Cited by 178
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Cooper, Z. D., & Haney, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00095.x · Cited by 158
Self-citationBupropion SR worsens mood during marijuana withdrawal in humans
Haney, M., Ward, A. S., Comer, S. D., Hart, C. L., Foltin, R. W., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130000657 · Cited by 135
Self-citationDronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood
Haney, M., Rabkin, J., Gunderson, E., & Foltin, R. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2242-2 · Cited by 126
Self-citationLevin, F. R., McDowell, D., Evans, S. M., Nunes, E., Akerele, E., Donovan, S., & Vosburg, S. K. (2004) · The American Journal on Addictions · doi:10.1080/10550490490265280 · Cited by 113
Carpenter, K. M., McDowell, D., Brooks, D. J., Cheng, W. Y., & Levin, F. R. (2009) · The American Journal on Addictions · doi:10.1080/10550490802408936 · Cited by 89
Dodge, R., Sindelar, J., & Sinha, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2004.12.005 · Cited by 89
Cui, S.-S., Bowen, R. C., Gu, G.-B., Hannesson, D. K., Yu, P. H., & Zhang, X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09867.2001 · Cited by 84
Bedi, G., Cooper, Z. D., & Haney, M. (2013) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00427.x · Cited by 83
Self-citationHaney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., & Cooper, Z. D. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.108 · Cited by 73
Self-citationLitt, M. D., Kadden, R. M., & Petry, N. M. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.08.011 · Cited by 71
Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use Disorders
Wilson, J. J., & Levin, F. R. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.751 · Cited by 71
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper, Z. D., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1875-y · Cited by 58
Self-citationDeWit, D. J., Hance, J., Offord, D. R., & Ogborne, A. (2000) · Preventive Medicine · doi:10.1006/pmed.2000.0738 · Cited by 54
Coccaro, E. F., Fanning, J. R., & Lee, R. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10306 · Cited by 38
Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers
Haney, M., Cooper, Z. D., Bedi, G., Herrmann, E., Comer, S. D., Reed, S. C., Foltin, R. W., & Levin, F. R. (2019) · Addiction Biology · doi:10.1111/adb.12621 · Cited by 31
Self-citationResidual cognitive effects of long-term cannabis use
Pope, H. G., & Yurgelun-Todd, D. (2004) · Marijuana and Madness · doi:10.1017/cbo9780511543630.015 · Cited by 7
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology
Holst, M., Mathai, D. S., Patel, M. M., Rodgman, C., Keller, J., Hussain, M. Z., De La Garza, R., Kosten, T. R., & Verrico, C. D. (2019) · The American Journal on Addictions · doi:10.1111/ajad.12959 · Cited by 5
Metadata
- Authors
- Haney, M., Ward, A. S., Comer, S. D., Foltin, R. W., & Fischman, M. W.
- Venue
- Psychopharmacology
- Published
- 1999-02-01
- Volume
- 141
- Issue
- 4
- Pages
- 395-404
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1965705101
- Cited by
- 353
- References
- 0
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.